Positive Physicians Holdings, Inc.
PPHI
$6.90
$0.000.00%
| Weiss Ratings | PPHI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | PPHI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | PPHI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.23 | |||
| Price History | PPHI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | 0.00% | |||
| 90-Day Total Return | 0.00% | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | 6.15% | |||
| 2-Year Total Return | -11.18% | |||
| 3-Year Total Return | -59.56% | |||
| 5-Year Total Return | -51.17% | |||
| 52-Week High % Change | -13.75% | |||
| 52-Week Low % Change | 6.15% | |||
| Price | PPHI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $8.00 | |||
| 52-Week Low Price | $6.50 | |||
| 52-Week Low Price (Date) | Apr 24, 2024 | |||
| 52-Week High Price (Date) | Aug 30, 2024 | |||
| Valuation | PPHI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 24.95M | |||
| Enterprise Value | -- | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.70 | |||
| Earnings Per Share Growth | 104.45% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.12 | |||
| Price/Book (Q) | 0.36 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $6.90 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | PPHI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 3.62M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | $1.11 | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | $1.11 | |||
| Company Info | PPHI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 888 335 5335 | |||
| Address | 100 Berwyn Park Berwyn, PA 19312 | |||
| Website | www.positivephysicians.com | |||
| Country | United States | |||
| Year Founded | 2002 | |||
| Profitability | PPHI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -14.35% | |||
| Profit Margin | -11.28% | |||
| Management Effectiveness | PPHI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -1.25% | |||
| Return on Equity | -- | |||
| Income Statement | PPHI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 21.98M | |||
| Total Revenue (TTM) | 22.34M | |||
| Revenue Per Share | $6.18 | |||
| Gross Profit (TTM) | 5.73M | |||
| EBITDA (TTM) | -2.03M | |||
| EBIT (TTM) | -3.21M | |||
| Net Income (TTM) | -2.52M | |||
| Net Income Avl. to Common (TTM) | -2.52M | |||
| Total Revenue Growth (Q YOY) | -0.94% | |||
| Earnings Growth (Q YOY) | 61.62% | |||
| EPS Diluted (TTM) | -0.70 | |||
| EPS Diluted Growth (Q YOY) | 63.18% | |||
| Balance Sheet | PPHI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 17.20M | |||
| Cash Per Share (Q) | $4.76 | |||
| Total Current Assets (Q) | 40.59M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 69.28M | |||
| Current Ratio (Q) | 2.061 | |||
| Book Value Per Share (Q) | $19.16 | |||
| Total Assets (Q) | 161.69M | |||
| Total Current Liabilities (Q) | 19.69M | |||
| Total Debt (Q) | 3.37M | |||
| Total Liabilities (Q) | 92.41M | |||
| Total Common Equity (Q) | 69.28M | |||
| Cash Flow | PPHI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -6.63M | |||
| Cash from Financing (TTM) | 2.70M | |||
| Net Change in Cash (TTM) | -1.54M | |||
| Levered Free Cash Flow (TTM) | 7.00M | |||
| Cash from Operations (TTM) | 2.38M | |||
